Calyxt, Inc. Common Stock

Compare this stock

CLXT Stock Report Card

Today's performance

51%

Performance

Score:

100/100

CLXT returned 80.96% in the last 12 months. Based on the other stocks in its sector with an average return of -17.48%, its performance is above average giving it a grade of 100 of 100.

Forecast

Score:

81/100

4 analysts offer 12-month price forecasts for CLXT. Together, they have an average target of 0, the most optimistic forecast put CLXT at 0 within 12-months and the most pessimistic has CLXT at 0.

Technicals

Score:

86/100

CLXT receives a 85 of 100 based on 14 indicators. 12 are bullish, 2 are bearish.

Earnings

Score:

10/100

CLXT has missed earnings 9 times in the last 20 quarters.

Profit

Score:

10/100

Out of the last 19 quarters, CLXT has had 0 profitable quarters and has increased their profits year over year on 0 of them.

Volatility

Score:

54/100

CLXT has had a higher than average amount of volatility over the last 12 months giving it a grade of 53 of 100.

Calyxt, Inc. Common Stock Summary

Nasdaq / CLXT

Consumer Defensive

Packaged Foods

Calyxt, Inc., a synthetic biology company, engages in delivering plant-based solutions primarily to the agriculture end market in the United States. The company is involved in the development of improved digestibility alfalfa; hemp; and wheat with a higher fiber content. It has a commercialization agreement with S&W Seed Company for the exclusive license of an improved quality alfalfa seed in the United States and internationally. The company was formerly known as Cellectis Plant Sciences, Inc. and changed its name to Calyxt, Inc. in May 2015. Calyxt, Inc. was incorporated in 2010 and is headquartered in Roseville, Minnesota. Calyxt, Inc. is a subsidiary of Cellectis S.A.

Power up your portfolio